- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Market capitalization of selected companies involved in fighting obesity 2019
Market capitalization of selected companies involved in fighting obesity 2019
Market capitalization of selected companies involved in fighting obesity, as of October 2019 (in billion U.S. dollars)
by Matej Mikulic,
last edited
Oct 9, 2019
This statistic represents the market capitalization of selected companies which are involved in fighting obesity, as of October 9, 2019. At this point, the market capitalization of Novo Nordisk, headquartered in Denmark, amounted to some 123.6 billion U.S. dollars.
Market capitalization of selected companies involved in fighting obesity, as of October 2019 (in billion U.S. dollars)
Loading statistic...
| Market capitalization in billion U.S. dollars | |
|---|---|
| Medtronic Inc. (U.S.) | 140.89 |
| Novo Nordisk (Denmark) | 123.6 |
| Stryker Corp. (U.S.) | 77.77 |
| Zimmer Biomet (U.S.) | 26.94 |
| Coloplast A/S (Denmark) | 24.96 |
| Smith & Nephew (UK) | 20.44 |
| Fresenius Medical Care (Germany) | 19.54 |
| DaVita Inc. (U.S.) | 7.5 |
| Getinge AB (Sweden)* | 3.76 |
| Rhythm Pharmaceuticals Inc (U.S.) | 0.67 |
| Market capitalization in billion U.S. dollars | |
|---|---|
| Medtronic Inc. (U.S.) | 140.89 |
| Novo Nordisk (Denmark) | 123.6 |
| Stryker Corp. (U.S.) | 77.77 |
| Zimmer Biomet (U.S.) | 26.94 |
| Coloplast A/S (Denmark) | 24.96 |
| Smith & Nephew (UK) | 20.44 |
| Fresenius Medical Care (Germany) | 19.54 |
| DaVita Inc. (U.S.) | 7.5 |
| Getinge AB (Sweden)* | 3.76 |
| Rhythm Pharmaceuticals Inc (U.S.) | 0.67 |
Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Register now
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Oct 9, 2019
This statistic represents the market capitalization of selected companies which are involved in fighting obesity, as of October 9, 2019. At this point, the market capitalization of Novo Nordisk, headquartered in Denmark, amounted to some 123.6 billion U.S. dollars.
- Show sources information
- Show publisher information
- Release date
- October 2019
- Region
- Worldwide
- Survey time period
- as of October 9, 2019
Source
- Show sources information
- Show publisher information
- Release date
- October 2019
More information
- Region
- Worldwide
- Survey time period
- as of October 9, 2019
Other statistics on the topic
+Pharmaceutical Products & Market
Leading pharmaceutical companies in Norway 2018, by turnover
+Pharmaceutical Products & Market
Leading pharmaceutical companies in Norway 2018, by market share
+Pharmaceutical Products & Market
Value of pharmaceutical sales in Norway 2000-2017
+Pharmaceutical Products & Market
Pharmaceutical preparations: manufacturing turnover in Norway 2007-2015
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Pharmaceutical industry in Norway "
- Overview
The most important statistics
- Value of pharmaceutical sales in Norway from 2000 to 2017 (in milllion NOK) Value of pharmaceutical sales in Norway 2000-2017
- Leading pharmaceutical companies in Norway in 2018, by turnover (in million NOK) Leading pharmaceutical companies in Norway 2018, by turnover
- Leading pharmaceutical companies in Norway in 2018, by market share Leading pharmaceutical companies in Norway 2018, by market share
- Producer price index (PPI) of chemical and pharmaceutical products in Norway from 2008 to 2018producer price index of chemical and pharmaceutical products in Norway 2008-2018
- Public expenditure on blue prescriptions* in Norway from 2013 to 2018 (in billion NOK) Public expenditure on blue prescriptions in Norway 2013-2018
- Number of pharmaceuticals available in Norway from 2013 to 2018 Number of pharmaceuticals available in Norway 2013-2018
- Leading nonprescription pharmaceutical companies in Norway in 2018, by market share Leading nonprescription pharmaceutical companies in Norway 2018, by market share
- Production and trade
The most important statistics
- Turnover of pharmaceutical preparation manufacturers in Norway from 2007 to 2015 (in million NOK)Pharmaceutical preparations: manufacturing turnover in Norway 2007-2015
- Number of establishments in the manufacture of pharmaceutical preparations industry in Norway from 2007 to 2017Number of pharmaceutical preparation establishments in Norway 2007-2017
- Number of employees in the manufacture of pharmaceutical preparations industry in Norway from 2007 to 2017Number of employees in pharmaceutical industry in Norway 2007-2017
- Import and export value of basic pharmaceutical products and pharmaceutical preparations in Norway in 2018 (in million NOK)Import and export value of basic pharmaceuticals in Norway 2018
- Import value of basic pharmaceutical products and pharmaceutical preparations into Norway from 2008 to 2018 (in million NOK)Import value of basic pharmaceuticals and preparations into Norway 2008-2018
- Export value of basic pharmaceutical products and pharmaceutical preparations from Norway from 2008 to 2018 (in million NOK)Export value of basic pharmaceuticals and preparations from Norway 2008-2018
- Pharmaceutical turnover
The most important statistics
- Turnover share of prescription pharmaceuticals in Norway in 2018, by prescription type (in million NOK) Turnover share of prescription drugs in Norway 2018, by prescription type
- Turnover of pharmaceuticals in Norway in 2017, by prescription type (in million NOK) Turnover of pharmaceuticals in Norway 2017, by prescription type
- Turnover share of generic pharmaceuticals in Norway from 2013 to 2018 (in DDD*) Turnover share of generic pharmaceuticals in Norway 2013-2018
- Turnover of pharmaceuticals in Norway in 2017, by type of drug (in million NOK)Turnover of pharmaceuticals in Norway 2017, by type of drug
- Turnover of pharmaceuticals in Norway in 2017, by ATC main groups (in million NOK) Turnover of pharmaceuticals in Norway 2017, by ATC main groups
- Turnover of nonprescription drugs in Norway from 2014 to 2018 (in million NOK) Turnover of nonprescription drugs in Norway 2014-2018
- R&D, patents and new products
The most important statistics
- Number of patents in the biotechnology sector in Norway from 2011 to 2017Number of biotechnology patents in Norway 2011-2017
- Number of applications for clinical trials in Norway from 2013 to 2018Number of applications for clinical trials in Norway 2013-2018
- Number of applications for clinical trials in Norway from 2013 to 2018, by type of actor Number of applications for clinical trials in Norway 2013-2018, by type of actor
- Volume share of pharmaceutical sales Norway in 2016, by introduction date Volume share of pharmaceutical sales in Norway 2016, by introduction date
- Number of new cancer pharmaceuticals approved by the European Medicines Agency (EMA) in Norway from 2014 to 2017 Number of new cancer pharmaceuticals approved by EMA in Norway 2014-2017
- Number of new and expired active substances in Norway from 2013 to 2018 Number of new and expired active substances in Norway 2013-2018
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Leading global pharmaceutical risers based on market capitalization 2018
- Market cap of select pharma companies with strong pipeline 2017
- U.S. medical per capita spending increase attributable to obesity by payer and services 19...
- Possible future obesity cost scenarios in the U.S. 2020
- Reduction of annual costs for obese U.S. persons by percentage of body weight loss 2012
- Highest obesity rate among 10-17 year-olds in U.S. by state 2016-2017
- Obesity and overweight among boys by ethnicity in the U.S. 2011-2014
- Total prescription drug revenue in Europe from top 10 companies 2015
- Total prescription drug revenues in Japan from top 10 companies 2015
- Prevalence of obesity adult population UAE 2007-2016
- Prevalence of obesity adult population Saudi Arabia 2007-2016
- U.S. adult obesity by age 2010-2012
- Weight status of U.S. children aged 10-17 years 2011
- Total number of pharmaceutical merger and acquisition deals 2004-2014
- U.S. adult obesity by gender 2010-2012
- Leading pharmaceutical companies by global anti-viral revenue 2017 and 2024
Studies
- Pharmaceutical industry in Scandinavia
- Novartis
- Pharmaceutical industry in Norway
- Eli Lilly
- Pharmaceutical trends in Europe
- Cardinal Health
- Pharma, Biotech & Medtech 2018 in Review
- Medtronic - 2019 Form 10-K
- Abbott Laboratories
- The State of Innovation in Highly Prevalent Chronic Diseases, Volume III
- Indicatori Farmaceutici
- Global pharmaceutical industry
- U.S. pharmaceutical industry
- Pharmaceutical industry in India
- Zoetis
Statistics on "Pharmaceutical industry in Norway - Overview"
- Value of pharmaceutical sales in Norway 2000-2017
- Leading pharmaceutical companies in Norway 2018, by turnover
- Leading pharmaceutical companies in Norway 2018, by market share
- producer price index of chemical and pharmaceutical products in Norway 2008-2018
- Public expenditure on blue prescriptions in Norway 2013-2018
- Number of pharmaceuticals available in Norway 2013-2018
- Leading nonprescription pharmaceutical companies in Norway 2018, by market share
Statistics on "Pharmaceutical industry in Norway - Production and trade "
- Pharmaceutical preparations: manufacturing turnover in Norway 2007-2015
- Number of pharmaceutical preparation establishments in Norway 2007-2017
- Number of employees in pharmaceutical industry in Norway 2007-2017
- Import and export value of basic pharmaceuticals in Norway 2018
- Import value of basic pharmaceuticals and preparations into Norway 2008-2018
- Export value of basic pharmaceuticals and preparations from Norway 2008-2018
Statistics on "Pharmaceutical industry in Norway - Pharmaceutical turnover "
- Turnover share of prescription drugs in Norway 2018, by prescription type
- Turnover of pharmaceuticals in Norway 2017, by prescription type
- Turnover share of generic pharmaceuticals in Norway 2013-2018
- Turnover of pharmaceuticals in Norway 2017, by type of drug
- Turnover of pharmaceuticals in Norway 2017, by ATC main groups
- Turnover of nonprescription drugs in Norway 2014-2018
Statistics on "Pharmaceutical industry in Norway - R&D, patents and new products "
- Number of biotechnology patents in Norway 2011-2017
- Number of applications for clinical trials in Norway 2013-2018
- Number of applications for clinical trials in Norway 2013-2018, by type of actor
- Volume share of pharmaceutical sales in Norway 2016, by introduction date
- Number of new cancer pharmaceuticals approved by EMA in Norway 2014-2017
- Number of new and expired active substances in Norway 2013-2018
Further related statistics
- Leading global pharmaceutical risers based on market capitalization 2018
- Market cap of select pharma companies with strong pipeline 2017
- U.S. medical per capita spending increase attributable to obesity by payer and services 1998-2006
- Possible future obesity cost scenarios in the U.S. 2020
- Reduction of annual costs for obese U.S. persons by percentage of body weight loss 2012
- Highest obesity rate among 10-17 year-olds in U.S. by state 2016-2017
- Obesity and overweight among boys by ethnicity in the U.S. 2011-2014
- Total prescription drug revenue in Europe from top 10 companies 2015
- Total prescription drug revenues in Japan from top 10 companies 2015
- Prevalence of obesity adult population UAE 2007-2016
- Prevalence of obesity adult population Saudi Arabia 2007-2016
- U.S. adult obesity by age 2010-2012
- Weight status of U.S. children aged 10-17 years 2011
- Total number of pharmaceutical merger and acquisition deals 2004-2014
- U.S. adult obesity by gender 2010-2012
- Leading pharmaceutical companies by global anti-viral revenue 2017 and 2024
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Statista Accounts:
Access All Statistics. Starting from $708 / Year
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$59 per month*
| |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.